IBDEI0WQ ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,42964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42964,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,42964,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,42964,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,42965,0)
 ;;=D05.81^^127^1855^36
 ;;^UTILITY(U,$J,358.3,42965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42965,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,42965,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,42965,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,42966,0)
 ;;=D05.80^^127^1855^38
 ;;^UTILITY(U,$J,358.3,42966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42966,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,42966,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,42966,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,42967,0)
 ;;=D56.8^^127^1855^186
 ;;^UTILITY(U,$J,358.3,42967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42967,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,42967,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,42967,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,42968,0)
 ;;=C82.89^^127^1855^76
 ;;^UTILITY(U,$J,358.3,42968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42968,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,42968,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,42968,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,42969,0)
 ;;=D51.8^^127^1855^193
 ;;^UTILITY(U,$J,358.3,42969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42969,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,42969,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,42969,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,42970,0)
 ;;=I80.9^^127^1855^178
 ;;^UTILITY(U,$J,358.3,42970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42970,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,42970,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,42970,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,42971,0)
 ;;=D45.^^127^1855^179
 ;;^UTILITY(U,$J,358.3,42971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42971,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,42971,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,42971,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,42972,0)
 ;;=C77.3^^127^1855^109
 ;;^UTILITY(U,$J,358.3,42972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42972,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,42972,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,42972,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,42973,0)
 ;;=C77.2^^127^1855^125
 ;;^UTILITY(U,$J,358.3,42973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42973,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,42973,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,42973,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,42974,0)
 ;;=C77.1^^127^1855^126
 ;;^UTILITY(U,$J,358.3,42974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42974,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,42974,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,42974,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,42975,0)
 ;;=C77.0^^127^1855^142
 ;;^UTILITY(U,$J,358.3,42975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42975,1,3,0)
 ;;=3^Malig Neop Nodes of Head,Face and Neck,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,42975,1,4,0)
 ;;=4^C77.0
 ;;^UTILITY(U,$J,358.3,42975,2)
 ;;=^5001329
 ;;^UTILITY(U,$J,358.3,42976,0)
 ;;=C77.8^^127^1855^143
 ;;^UTILITY(U,$J,358.3,42976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42976,1,3,0)
 ;;=3^Malig Neop Nodes of Multiple Regions,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,42976,1,4,0)
 ;;=4^C77.8
 ;;^UTILITY(U,$J,358.3,42976,2)
 ;;=^5001332
 ;;^UTILITY(U,$J,358.3,42977,0)
 ;;=C79.51^^127^1855^113
 ;;^UTILITY(U,$J,358.3,42977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42977,1,3,0)
 ;;=3^Malig Neop Bone,Secondary
 ;;^UTILITY(U,$J,358.3,42977,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,42977,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,42978,0)
 ;;=C79.52^^127^1855^112
 ;;^UTILITY(U,$J,358.3,42978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42978,1,3,0)
 ;;=3^Malig Neop Bone Marrow,Secondary
 ;;^UTILITY(U,$J,358.3,42978,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,42978,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,42979,0)
 ;;=C79.31^^127^1855^114
 ;;^UTILITY(U,$J,358.3,42979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42979,1,3,0)
 ;;=3^Malig Neop Brain,Secondary
 ;;^UTILITY(U,$J,358.3,42979,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,42979,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,42980,0)
 ;;=C79.72^^127^1855^129
 ;;^UTILITY(U,$J,358.3,42980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42980,1,3,0)
 ;;=3^Malig Neop Left Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,42980,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,42980,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,42981,0)
 ;;=C78.02^^127^1855^133
 ;;^UTILITY(U,$J,358.3,42981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42981,1,3,0)
 ;;=3^Malig Neop Left Lung,Secondary
 ;;^UTILITY(U,$J,358.3,42981,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,42981,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,42982,0)
 ;;=C78.7^^127^1855^138
 ;;^UTILITY(U,$J,358.3,42982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42982,1,3,0)
 ;;=3^Malig Neop Liver/Intrahepatic Bile Duct,Secondary
 ;;^UTILITY(U,$J,358.3,42982,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,42982,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,42983,0)
 ;;=C79.71^^127^1855^151
 ;;^UTILITY(U,$J,358.3,42983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42983,1,3,0)
 ;;=3^Malig Neop Right Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,42983,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,42983,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,42984,0)
 ;;=C78.01^^127^1855^155
 ;;^UTILITY(U,$J,358.3,42984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42984,1,3,0)
 ;;=3^Malig Neop Right Lung,Secondary
 ;;^UTILITY(U,$J,358.3,42984,1,4,0)
 ;;=4^C78.01
 ;;^UTILITY(U,$J,358.3,42984,2)
 ;;=^5001335
 ;;^UTILITY(U,$J,358.3,42985,0)
 ;;=C79.70^^127^1855^106
 ;;^UTILITY(U,$J,358.3,42985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42985,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,42985,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,42985,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,42986,0)
 ;;=C78.00^^127^1855^139
 ;;^UTILITY(U,$J,358.3,42986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42986,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,42986,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,42986,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,42987,0)
 ;;=D57.1^^127^1855^182
 ;;^UTILITY(U,$J,358.3,42987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42987,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,42987,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,42987,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,42988,0)
 ;;=D75.1^^127^1855^180
 ;;^UTILITY(U,$J,358.3,42988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42988,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,42988,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,42988,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,42989,0)
 ;;=C90.30^^127^1855^183
 ;;^UTILITY(U,$J,358.3,42989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42989,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,42989,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,42989,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,42990,0)
 ;;=D56.3^^127^1855^184
 ;;^UTILITY(U,$J,358.3,42990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42990,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,42990,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,42990,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,42991,0)
 ;;=D56.9^^127^1855^185
 ;;^UTILITY(U,$J,358.3,42991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42991,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,42991,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,42991,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,42992,0)
 ;;=M31.1^^127^1855^187
 ;;^UTILITY(U,$J,358.3,42992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42992,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,42992,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,42992,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,42993,0)
 ;;=D51.2^^127^1855^188
 ;;^UTILITY(U,$J,358.3,42993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42993,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,42993,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,42993,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,42994,0)
 ;;=D05.92^^127^1855^35
 ;;^UTILITY(U,$J,358.3,42994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42994,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,42994,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,42994,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,42995,0)
 ;;=D05.91^^127^1855^37
 ;;^UTILITY(U,$J,358.3,42995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42995,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,42995,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,42995,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,42996,0)
 ;;=D05.90^^127^1855^33
 ;;^UTILITY(U,$J,358.3,42996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42996,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,42996,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,42996,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,42997,0)
 ;;=D51.0^^127^1855^189
 ;;^UTILITY(U,$J,358.3,42997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42997,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,42997,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,42997,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,42998,0)
 ;;=D51.1^^127^1855^190
 ;;^UTILITY(U,$J,358.3,42998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42998,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,42998,1,4,0)
 ;;=4^D51.1
